ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) announced today that nineteen research and clinical papers on thymosin beta 4 (Tß4) have been published in the May 2010 issue of the Annals of the New York Academy of Sciences, volume 1194. Preliminary research and clinical data were presented at the “2nd International Symposium on Thymosins in Health and Disease” in September, 2009.
